Clinical Trial: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Brief Summary: The purpose of this study is to determine whether Imatinib Mesylate is active in diseases - such as Desmoid Tumor and Chondrosarcoma - expressing the receptor for the platelet-derived growth factor (PDGF) both in its isoform alpha and beta

Detailed Summary:
Sponsor: Italian Sarcoma Group

Current Primary Outcome: Tumor response will be evaluated by different imaging techniques [ Time Frame: every three months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Italian Sarcoma Group

Dates:
Date Received: June 25, 2009
Date Started: May 2007
Date Completion: December 2016
Last Updated: September 9, 2016
Last Verified: September 2016